Patents : |  |
| US Patent No. | Title |
| 7371825 | Anti-MCP-1 antibodies, compositions, methods and uses
|
| 7452538 | Death domain containing receptor 4 antibodies and methods
|
| 7456256 | BGS 4
|
| 7456288 | Heterocyclic compounds and methods of making and using thereof
|
| 7459531 | 50 Human secreted proteins
|
| 7459532 | Variants of the TRP channel family member, LTRPC3G
|
| 7465707 | Methods of treatment with TR10 polypeptides
|
| 7476384 | Death domain containing receptor 4 antibody and methods
|
| 7482013 | Albumin fusion proteins
|
| 7482334 | Therapeutic treatment methods
|
| 7491391 | Anti-IL-23 antibodies, compositions, methods and uses
|
| 7446176 | 12 human secreted proteins
|
| 7439241 | Compounds, formulations, and methods for treating or preventing rosacea
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7381722 | Tetracyclic amino and carboxamido compounds and methods of use thereof
|
| 7381800 | Antibodies to HBIMF63 polypeptide
|
| 7390637 | Keratinocyte derived interferon
|
| 7393662 | Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
| 7393934 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7402312 | Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7425622 | Antibodies against C3a receptor
|
| 7429575 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
|
| 7429646 | Antibodies to human tumor necrosis factor receptor-like 2
|
| 7498027 | Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
|
| 7501123 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7560112 | Anti-il-6 antibodies, compositions, methods and uses
|
| 7560247 | Nucleic acids encoding anti-IL-12 antibodies, and methods of production
|
| 7569384 | Albumin fusion proteins
|
| 7572618 | Polynucleotides encoding novel PCSK9 variants
|
| 7572776 | N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
|
| 7592010 | Albumin fusion proteins
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7605174 | Indane derivatives as modulators of ion channels
|
| 7550569 | Antibodies that specifically bind to GMAD
|
| 7550142 | Anti-integrin antibodies, compositions, methods and uses
|
| 7547767 | Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
|
| 7504105 | Treatment using antibodies to cytokine receptor common gamma chain like
|
| 7504481 | TRP channel family member, LTRPC3 polypeptides
|
| 7507413 | Albumin fusion proteins
|
| 7507414 | Albumin fusion proteins
|
| 7511017 | Methods of treatment with TNFR5
|
| 7514079 | Antibodies that specifically bind to neurokinin B
|
| 7521206 | Anti-TNF antibodies, compositions, methods and uses
|
| 7531310 | Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11
|
| 7534428 | Antibodies to tumor necrosis factor receptors 6.alpha. and 6.beta.
|
| 7547687 | Therapeutic treatment methods
|
| 7612181 | Dual variable domain immunoglobulin and uses thereof
|
